Dyne Therapeutics Inc is a company in the U.S. stock market and it is a holding in 32 U.S.-traded ETFs. DYN has around 1.8M shares in the U.S. ETF market. The largest ETF holder of DYN is the iShares Russell 2000 ETF (IWM), with approximately 656.53K shares. Investors may also find of interest that the ETF with the largest allocation to DYN stock is Direxion mRNA ETF (MSGR), with a portfolio weight of 6.23%. On average, U.S. ETFs allocate 0.21% of DYN to their portfolios.
Additionally, DYN is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with DYN as a holding is the Dimensional U.S. Targeted Value ETF (DFAT), with a return of 3.78%.